Table 12.12a

Unadjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,032 91.2% 0.6% 2,032 83.0% 0.8% 3,962 64.5% 0.9% 5,620 49.3% 0.9%
Primary Diagnosis Emphysema/COPD 818 93.6% 0.9% 818 86.1% 1.2% 1,689 66.1% 1.4% 2,392 49.5% 1.5%
Cystic Fibrosis 316 93.7% 1.4% 316 84.5% 2.0% 618 66.3% 2.3% 886 52.6% 2.3%
Idiopathic Pulmonary Fibrosis 436 88.8% 1.5% 436 80.3% 1.9% 734 62.2% 2.2% 1,011 43.3% 2.3%
Alpha-1-Antitrypsin Deficiency 142 91.5% 2.3% 142 83.1% 3.1% 291 65.3% 3.1% 421 47.1% 3.4%
Primary Pulmonary Hypertension 88 76.1% 4.5% 88 75.0% 4.6% 161 59.1% 4.5% 239 57.6% 3.6%
Congenital Disease 19 84.2% 8.4% 19 84.2% 8.4% 40 57.8% 9.6% 70 48.7% 7.0%
Other 211 90.5% 2.0% 211 78.2% 2.8% 426 63.3% 2.7% 594 51.5% 2.7%
Unknown 2 0.0% 0.0% 2 0.0% 0.0% 3 0.0% 0.0% 7 42.9% 18.7%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.